Condition: Lymphedema, Secondary · Lymphedema of Upper Limb · Lymphedema, Lower Limb · Sponsor: Maastricht University Medical Center
The goal of this randomized controlled trial is to compare the effectiveness and cost-effectiveness of lymphaticovenous anastomosis (LVA) with sham surgery for patients suffering from unilateral cancer-related lymphedema in either the upper or lower extremity. It aims to answer whether LVA is more effective than sham surgery in terms of improvement in Lymph-ICF score. A total of 110 participants will be allocated randomly into two groups at a 1:1 ratio. The first group will receive lymphaticovenous anastomosis (LVA), while the second group will undergo sham surgery.
This description comes directly from the study's public registry record.
Tanya Wolffenbuttel, MSc · +31(0)433877481 · t.wolffenbuttel@erasmusmc.nl/tanya.wolffenbuttel@mumc.nl
Always discuss trial participation with your own doctor first.
| Radboud University Medical Center | Nijmegen, Gelderland, Netherlands | Recruiting |
| Maastricht University Medical Center | Maastricht, Limburg, Netherlands | Recruiting |
| Erasmus University Medical Center | Rotterdam, South Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06082349